Tenofovir disoproxil fumarate treatment in HbeAg-positive patients.

Abstract

Tenofovir disoproxil fumarate (Tenofovir DF) is a nucleotide analogue. This multicentre study reports retrospectively the long-term efficacy and safety data with tenofovir DF treatment in nucleosid(t)e-naive, hepatitis B e antigen (HBeAg)-positive chronic hepatitis B patients. Thirty-one patients (11 females, 20 males) received 245 mg tenofovir DF per diem… (More)

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.